177 related articles for article (PubMed ID: 24301060)
21. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
22. Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor.
Dewire MD; Ellison DW; Patay Z; McKinnon PJ; Sanders RP; Gajjar A
Pediatr Blood Cancer; 2009 Dec; 53(6):1140-2. PubMed ID: 19530235
[TBL] [Abstract][Full Text] [Related]
23. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood.
Hirsch B; Shimamura A; Moreau L; Baldinger S; Hag-alshiekh M; Bostrom B; Sencer S; D'Andrea AD
Blood; 2004 Apr; 103(7):2554-9. PubMed ID: 14670928
[TBL] [Abstract][Full Text] [Related]
24. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression.
Chen X; Truong TT; Weaver J; Bove BA; Cattie K; Armstrong BA; Daly MB; Godwin AK
Hum Mutat; 2006 May; 27(5):427-35. PubMed ID: 16619214
[TBL] [Abstract][Full Text] [Related]
25. The zebrafish kidney mutant zeppelin reveals that brca2/fancd1 is essential for pronephros development.
Kroeger PT; Drummond BE; Miceli R; McKernan M; Gerlach GF; Marra AN; Fox A; McCampbell KK; Leshchiner I; Rodriguez-Mari A; BreMiller R; Thummel R; Davidson AJ; Postlethwait J; Goessling W; Wingert RA
Dev Biol; 2017 Aug; 428(1):148-163. PubMed ID: 28579318
[TBL] [Abstract][Full Text] [Related]
26. Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.
Machackova E; Foretova L; Lukesova M; Vasickova P; Navratilova M; Coene I; Pavlu H; Kosinova V; Kuklova J; Claes K
BMC Cancer; 2008 May; 8():140. PubMed ID: 18489799
[TBL] [Abstract][Full Text] [Related]
27. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ
Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163
[TBL] [Abstract][Full Text] [Related]
28. Multiplexed CRISPR/Cas9-mediated knockout of 19 Fanconi anemia pathway genes in zebrafish revealed their roles in growth, sexual development and fertility.
Ramanagoudr-Bhojappa R; Carrington B; Ramaswami M; Bishop K; Robbins GM; Jones M; Harper U; Frederickson SC; Kimble DC; Sood R; Chandrasekharappa SC
PLoS Genet; 2018 Dec; 14(12):e1007821. PubMed ID: 30540754
[TBL] [Abstract][Full Text] [Related]
29. Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling.
Meyer S; Tischkowitz M; Chandler K; Gillespie A; Birch JM; Evans DG
J Med Genet; 2014 Feb; 51(2):71-5. PubMed ID: 24259538
[TBL] [Abstract][Full Text] [Related]
30. [Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene--Case Report].
Puchmajerová A; Švojgr K; Novotná D; Macháčková E; Sumerauer D; Smíšek P; Kodet R; Kynčl M; Křepelová A; Foretová L
Klin Onkol; 2016; 29 Suppl 1():S89-92. PubMed ID: 26691948
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.
Guénard F; Labrie Y; Ouellette G; Joly Beauparlant C; Simard J; ; Durocher F
J Hum Genet; 2008; 53(7):579. PubMed ID: 18414782
[TBL] [Abstract][Full Text] [Related]
32. Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members.
Thomassen M; Blanco A; Montagna M; Hansen TV; Pedersen IS; Gutiérrez-Enríquez S; Menéndez M; Fachal L; Santamariña M; Steffensen AY; Jønson L; Agata S; Whiley P; Tognazzo S; Tornero E; Jensen UB; Balmaña J; Kruse TA; Goldgar DE; Lázaro C; Diez O; Spurdle AB; Vega A
Breast Cancer Res Treat; 2012 Apr; 132(3):1009-23. PubMed ID: 21769658
[TBL] [Abstract][Full Text] [Related]
33. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
[TBL] [Abstract][Full Text] [Related]
34. Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to
Ip E; McNeil C; Grimison P; Scheinberg T; Tudini E; Ho G; Scott RJ; Brown C; Sandroussi C; Guitera P; Spurdle AB; Goodwin A
J Med Genet; 2022 Sep; 59(9):912-915. PubMed ID: 34697207
[TBL] [Abstract][Full Text] [Related]
35. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
[TBL] [Abstract][Full Text] [Related]
36. Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia.
Pouliot GP; Degar J; Hinze L; Kochupurakkal B; Vo CD; Burns MA; Moreau L; Ganesa C; Roderick J; Peirs S; Menten B; Loh ML; Hunger SP; Silverman LB; Harris MH; Stevenson KE; Weinstock DM; Weng AP; Van Vlierberghe P; D'Andrea AD; Gutierrez A
PLoS One; 2019; 14(11):e0221288. PubMed ID: 31721781
[TBL] [Abstract][Full Text] [Related]
37. Fanconi anaemia and cancer: an intricate relationship.
Nalepa G; Clapp DW
Nat Rev Cancer; 2018 Mar; 18(3):168-185. PubMed ID: 29376519
[TBL] [Abstract][Full Text] [Related]
38. Fanconi anemia-D1 due to homozygosity for the BRCA2 gene Cypriot founder mutation: A case report.
Loizidou MA; Hadjisavvas A; Tanteles GA; Spanou-Aristidou E; Kyriacou K; Christophidou-Anastasiadou V
Oncol Lett; 2016 Jan; 11(1):471-473. PubMed ID: 26834852
[TBL] [Abstract][Full Text] [Related]
39. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
Meindl A;
Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
